DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/dcbd93/future_horizons) has announced the addition of the "Future Horizons in the Global Aeromonads Diagnostic Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country" report to their offering.
“Future Horizons in the Global Aeromonads Diagnostic Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country”
The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 200 pages and 7 tables
Competitive Assessments Include:
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
For more information visit http://www.researchandmarkets.com/research/dcbd93/future_horizons





